APPLIED MOLECULAR TRANS INC's ticker is AMTI and the CUSIP is 03824M109. A total of 28 filers reported holding APPLIED MOLECULAR TRANS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,644 | -39.1% | 55,055 | 0.0% | 0.00% | – |
| Q2 2023 | $14,204 | -19.4% | 55,055 | 0.0% | 0.00% | – |
| Q1 2023 | $17,618 | -61.9% | 55,055 | -50.0% | 0.00% | – |
| Q4 2022 | $46,246 | -14.4% | 110,110 | +100.0% | 0.00% | – |
| Q3 2022 | $54,000 | -66.2% | 55,055 | 0.0% | 0.00% | – |
| Q2 2022 | $160,000 | -95.3% | 55,055 | -87.9% | 0.00% | – |
| Q1 2022 | $3,431,000 | -42.6% | 456,271 | +6.6% | 0.00% | – |
| Q4 2021 | $5,981,000 | -81.5% | 427,839 | -65.8% | 0.00% | -100.0% |
| Q3 2021 | $32,393,000 | -41.5% | 1,252,151 | +3.5% | 0.00% | -33.3% |
| Q2 2021 | $55,339,000 | +133.3% | 1,209,861 | +124.5% | 0.00% | +200.0% |
| Q1 2021 | $23,719,000 | +43.5% | 538,940 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $16,529,000 | +225.8% | 537,194 | +236.9% | 0.00% | – |
| Q3 2020 | $5,074,000 | – | 159,469 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EPIQ Capital Group, LLC | 9,098,780 | $68,423,000 | 18.70% |
| Founders Fund VI Management, LLC | 826,607 | $6,216,000 | 10.49% |
| Founders Fund V Management, LLC | 3,611,615 | $27,159,000 | 1.74% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 320,000 | $2,406,000 | 0.20% |
| Avoro Capital Advisors LLC | 1,030,000 | $7,746,000 | 0.14% |
| Burleson & Company, LLC | 73,803 | $555,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 71,073 | $534,000 | 0.07% |
| Virtus ETF Advisers LLC | 11,621 | $87,000 | 0.04% |
| EcoR1 Capital, LLC | 131,693 | $990,000 | 0.03% |
| Trexquant Investment LP | 88,445 | $665,000 | 0.03% |